ten Bosch John Roderick sold $170K of BLLN
ten Bosch John Roderick (SVP of Laboratory Operations) sold 1,416 shares of BillionToOne, Inc. (BLLN) at $120.00 ($0.17M total) on 2026-06-29 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price, and that it was executed under a pre-arranged Rule 10b5-1 plan; no other company developments are included.
Market read
This provides a datapoint on insider selling activity but lacks any fundamental catalyst, making it more useful for monitoring than for immediate re-rating.
What to watch
The article provides only one sale and does not include buy transactions, option exercises, or broader insider activity trends; without that context, signal strength is limited.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for BillionToOne, Inc.
Ticker impact
BillionToOne disclosed an SVP open-market sale of 1,416 shares at $120 on a 10b5-1 plan via a Form 4 filed July 1.
Low likelihood of a sustained price move solely from this Form 4; any reaction is likely muted and short-lived.
The filing is a standard insider transaction (Code S) explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying operational, financial, or regulatory catalyst described.
Market effects
Minimal—this is company-specific insider liquidity with no sector-wide datapoint.
None indicated.
None indicated.
Counterpoint
Even 10b5-1 sales can coincide with periods of heightened insider caution; traders may still watch for follow-on selling or clustering of insider transactions.
Key entities
- issuerBillionToOne, Inc.
Subject of the Form 4 insider transaction disclosure (BLLN).
- insiderten Bosch John Roderick
SVP of Laboratory Operations who sold shares under a 10b5-1 plan.
